Zydus Lifesciences Limited (NSE:ZYDUSLIFE)

Zydus Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	1,117,204	876,631	891,926	1,013,630	497,549	356,774
Market Cap Growth	11.46%	-1.71%	-12.01%	103.72%	39.46%	-20.96%
Enterprise Value	1,217,347	930,186	892,181	1,022,435	525,557	387,118
Last Close Price	1120.00	870.42	875.57	992.57	479.86	337.79

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	24.97	17.39	19.71	26.26	25.38	7.95
Forward PE	26.19	20.54	19.01	28.46	21.39	16.57
PS Ratio	3.91	3.23	3.84	5.19	2.89	2.36
PB Ratio	3.78	2.96	3.38	4.59	2.53	1.87
P/TBV Ratio	11.51	9.03	5.76	8.48	4.28	3.40
P/FCF Ratio	-	-	17.53	44.27	30.01	39.56
P/OCF Ratio	52.78	41.42	13.15	31.71	18.50	16.95
PEG Ratio	11.15	2.29	2.15	1.53	1.79	3.03

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	4.26	3.43	3.84	5.23	3.05	2.56
EV/EBITDA Ratio	17.55	12.98	13.06	19.45	14.87	12.21
EV/EBIT Ratio	22.34	15.97	14.97	22.53	18.42	15.65
EV/FCF Ratio	-	-	17.54	44.65	31.70	42.92

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.42	0.42	0.12	0.04	0.06	0.22
Debt / EBITDA Ratio	1.83	1.74	0.47	0.16	0.34	1.33
Debt / FCF Ratio	-	-	0.63	0.36	0.72	4.68
Net Debt / Equity Ratio	0.26	0.26	-0.09	-0.02	0	0.01
Net Debt / EBITDA Ratio	1.11	1.05	-0.35	-0.10	0.00	0.08
Net Debt / FCF Ratio	-	-5.90	-0.48	-0.23	0.00	0.27
Asset Turnover	-	0.61	0.70	0.71	0.64	0.59
Inventory Turnover	-	1.57	1.77	1.87	1.81	1.64
Quick Ratio	-	0.67	1.13	1.30	1.05	0.96
Current Ratio	-	1.27	1.89	2.14	1.81	1.54
Return on Equity (ROE)	-	18.32%	19.28%	18.90%	10.82%	13.96%
Return on Assets (ROA)	-	8.13%	11.21%	10.31%	6.66%	5.98%
Return on Invested Capital (ROIC)	10.84%	14.55%	20.12%	17.64%	11.43%	10.78%
Return on Capital Employed (ROCE)	-	15.90%	21.20%	19.00%	14.10%	12.40%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	4.04%	5.75%	5.07%	3.81%	3.94%	12.58%
FCF Yield	-1.14%	-1.46%	5.70%	2.26%	3.33%	2.53%
Dividend Yield	0.09%	0.11%	1.26%	0.30%	1.25%	0.74%
Payout Ratio	-	21.95%	6.68%	16.09%	13.63%	8.29%
Buyback Yield / Dilution	0.02%	-	0.56%	0.37%	0.79%	-
Total Shareholder Return	0.10%	0.11%	1.82%	0.67%	2.04%	0.74%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error